Abstract
Purpose
Ophthalmic histiocytic lesions comprise a heterogeneous rare group of disorders that are characterized by an abnormal proliferation of histiocytes and may affect all age groups of both sexes. The aim of this study was to highlight the basic demographic, clinical, and histopathological characteristics of this rare group of diseases in ophthalmic practice, which has not been previously studied in this area. Only individual cases have been previously reported.
Methods
This was a retrospective study of all biopsied ocular and periocular histiocytic lesions from two centers, King Khaled Eye Specialist Hospital (KKESH) and King Abdulaziz University Hospital (KAUH) in Riyadh, Saudi Arabia, from January 1993 to December 2018. The histopathological diagnosis was confirmed, and the cases were re-classified by reviewing all histopathological slides. The corresponding demographic and clinical data were analyzed. A relevant literature review was also carried out for comparison of our collected analyzed data to published data and to draw our own conclusions.
Results
A total of 34 ocular/periocular histiocytic lesions in 28 patients who were mostly Saudis (92.9%) were included. The male-to-female ratio was 4:3. The median age at presentation was 6.4 years (range: 2.8–35 years). Twenty-two patients had unilateral involvement, and six patients had bilateral lesions. In patients with Langerhans cell histiocytosis (LCH; L group), the most common presenting findings were eyelid swelling (75%), periocular tenderness (37.5%), proptosis/globe displacement (37.5%) eyelid erythema (25%), and orbital pain (12.5%). In patients with Rosai Dorfman disease (RDD; R group), proptosis/globe displacement occurred in all patients and 80% had decreased vision. Patients in the C group (Cutaneous non-LCH histiocytoses) had variable clinical features because of the different locations of the histiocytic lesions, with the majority involving the eyelids (66.7%). Diagnosis was accurately reached clinically in 38.8%, 33.7%, and 46.7% of patients in the L, C, and R groups, respectively. Overall, the clinical diagnosis was in concordance with the histopathologic diagnosis in 14 out of 34 lesions (41.2%).
Conclusions
Histiocytic disease is more likely to be overlooked clinically owing to its rarity. In the C group, juvenile xanthogranuloma (JXG) was the most commonly encountered histiocytic lesion and had a tendency to present at a later age with extremely rare intraocular involvement in contrast to previously published reports. The median age at presentation was higher in group R. All patients in group L had strictly unilateral disease, while RDD (group R) was most commonly bilateral. Future research on genetic aspects, management, and prognosis is necessary.
Similar content being viewed by others
Data availability
Data for this study are submitted as a supplementary file.
References
Lichtenstein L, Histiocytosis X (1953) Integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schuller-Christian disease as related manifestations of a single nosologic entity. AMA Arch Pathol 56(1):84–102
Moore AT, Pritchard J, Taylor DS (1985) Histiocytosis X: an ophthalmological review. Br J Ophthalmol 69(1):7–14
Histiocytosis syndromes in children (1987) Writing group of the histiocyte society. Lancet (London, England) 1(8526):208–209
Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M et al (1997) Contemporary classification of histiocytic disorders. the WHO committee on Histiocytic/Reticulum cell proliferations. Reclassification working group of the histiocyte society. Med Pediatr Oncol 29(3):157–166
Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J et al (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127(22):2672–2681
Harris GJ (2006) Langerhans cell histiocytosis of the orbit: a need for interdisciplinary dialogue. Am J Ophthalmol 141(2):374–378
Lam S, Reddy GD, Mayer R, Lin Y, Jea A (2015) Eosinophilic granuloma/Langerhans cell histiocytosis: Pediatric neurosurgery update. Surg Neurol Int 6(Suppl 17):S435–S439
Denaro L, Longo UG, Papalia R, Di Martino A, Maffulli N, Denaro V (2008) Eosinophilic granuloma of the pediatric cervical spine. Spine 33(24):E936–E941
Kasper EM, Aguirre-Padilla DH, Alter RY, Anderson M (2011) Histiocytosis X: characteristics, behavior, and treatments as illustrated in a case series. Surg Neurol Int 2:57
Meyer JS, De Camargo B (1998) The role of radiology in the diagnosis and follow-up of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 12(2):307–326
Demirci H, Shields CL, Shields JA, Eagle RC Jr (2002) Bilateral sequential orbital involvement by eosinophilic granuloma. Arch Ophthalmol 120(7):978–9
Woo KI, Harris GJ (2003) Eosinophilic granuloma of the orbit: understanding the paradox of aggressive destruction responsive to minimal intervention. Ophthalmic Plast Reconstr Surg 19(6):429–439
Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, Grois N et al (2003) Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 39(16):2341–82348
Hamre M, Hedberg J, Buckley J, Bhatia S, Finlay J, Meadows A et al (1997) Langerhans cell histiocytosis: an exploratory epidemiologic study of 177 cases. Med Pediatr Oncol 28(2):92–97
Laman JD, Leenen PJ, Annels NE, Hogendoorn PC, Egeler RM (2003) Langerhans-cell histiocytosis “insight into DC biology.” Trends Immunol 24(4):190–196
Guyot-Goubin A, Donadieu J, Barkaoui M, Bellec S, Thomas C, Clavel J (2008) Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000–2004. Pediatr Blood Cancer 51(1):71–75
Stalemark H, Laurencikas E, Karis J, Gavhed D, Fadeel B, Henter JI (2008) Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer 51(1):76–81
Alston RD, Tatevossian RG, McNally RJ, Kelsey A, Birch JM, Eden TO (2007) Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatr Blood Cancer 48(5):555–560
Salotti JA, Nanduri V, Pearce MS, Parker L, Lynn R, Windebank KP (2009) Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Arch Dis Child 94(5):376–380
Maccheron LJ, McNab AA, Elder J, Selva D, Martin FJ, Clement CI et al (2006) Ocular adnexal Langerhans cell histiocytosis clinical features and management. Orbit (Amsterdam, Netherlands) 25(3):169–177
Arico M, Haupt R, Russotto VS, Bossi G, Scappaticci S, Danesino C (2001) Langerhans cell histiocytosis in two generations: a new family and review of the literature. Med Pediatr Oncol 36(2):314–316
Laurencikas E, Gavhed D, Stalemark H, van’t Hooft I, Prayer D, Grois N et al (2011) Incidence and pattern of radiological central nervous system Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood & Cancer 56(2):250–257
Kramer TR, Noecker RJ, Miller JM, Clark LC (1997) Langerhans cell histiocytosis with orbital involvement. Am J Ophthalmol 124(6):814–824
Mokal NJ, Shetty KP, Arora R, Thatte MR (2001) Langerhans cell histiocytosis: Orbital involvement as an unusual location. Plast Reconstr Surg 107(3):813–817
Vosoghi H, Rodriguez-Galindo C, Wilson MW (2009) Orbital involvement in langerhans cell histiocytosis. Ophthalmic Plast Reconstr Surg 25(6):430–433
Jubran RF, Marachelian A, Dorey F, Malogolowkin M (2005) Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer 45(1):37–42
Jakobiec FA, Trokel SL, Aron-Rosa D, Iwamoto T, Doyon D (1980) Localized eosinophilic granuloma (Langerhans’ cell histiocytosis) of the orbital frontal bone. Arch Ophthalmol 98(10):1814–1820
Levy J, Monos T, Kapelushnik J, Maor E, Nash M, Lifshitz T (2004) Ophthalmic manifestations in Langerhans cell histiocytosis. Isr Med Assoc J IMAJ 6(9):553–555
Zausinger S, Muller A, Bise K, Klauss V (2000) Eosinophilic granuloma of the orbit in an adult woman. Acta Neurochir 142(2):215–217
Gunduz K, Palamar M, Parmak N, Kuzu I (2007) Eosinophilic granuloma of the orbit: Report of two cases. J AAPOS: Off Publ Am Assoc Pediatr Ophthalmol Strabismus 11(5):506–508
Enriquez P, Dahlin DC, Hayles AB, Henderson ED (1967) Histiocytosis X: a clinical study. Mayo Clin Proc 42(2):88–99
Herwig MC, Wojno T, Zhang Q, Grossniklaus HE (2013) Langerhans cell histiocytosis of the orbit: Five clinicopathologic cases and review of the literature. Surv Ophthalmol 58(4):330–340
Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, Hershkovitz-Rokah O, Girschikofsky M, Jacobsen ED, Toyama K, Goodman AM, Hendrie P, Cao XX, Estrada-Veras JI, Shpilberg O, Abdo A, Kurokawa M, Dagna L, McClain KL, Mazor RD, Picarsic J, Janku F, Go RS, Haroche J, Diamond EL (2020) Erdheim-Chester disease: Consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 135(22):1929–1945. https://doi.org/10.1182/blood.2019003507 (PMID: 32187362)
Dehner LP (2003) Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 27(5):579–593
Sanders TE (1960) Intraocular juvenile xanthogranuloma (nevoxanthogranuloma): a survey of 20 cases. Trans Am Ophthalmol Soc 58:59–74
Zimmerman LE (1965) Ocular lesions of juvenile xanthogranuloma: Nevoxanthoedothelioma. Am J Ophthalmol 60(6):1011–1035
DeBarge LR, Chan CC, Greenberg SC, McLean IW, Yannuzzi LA, Nussenblatt RB (1994) Chorioretinal, iris, and ciliary body infiltration by juvenile xanthogranuloma masquerading as uveitis. Surv Ophthalmol 39(1):65–71
Wertz FD, Zimmerman LE, McKeown CA, Croxatto JO, Whitmore PV, LaPiana FG (1982) Juvenile xanthogranuloma of the optic nerve, disc, retina, and choroid. Ophthalmology 89(12):1331–1335
Hildebrand GD, Timms C, Thompson DA, Atherton DJ, Malone M, Levitt G et al (2004) Juvenile xanthogranuloma with presumed involvement of the optic disc and retina. Arch Ophthalmol 122(10):1551–1555
Johnson TE, Alabiad C, Wei L, Davis JA (2010) Extensive juvenile xanthogranuloma involving the orbit, sinuses, brain, and subtemporal fossa in a newborn. Ophthalmic Plast Reconstr Surg 26(2):133–134
Hayashi N, Komatsu T, Komatsu T, Hiroi M, Ueno H (2004) Juvenile xanthogranuloma presenting with unilateral prominent nodule of the eyelid: Report of a case and clinicopathological findings. Jpn J Ophthalmol 48(5):435–439
Kuruvilla R, Escaravage GK Jr, Finn AJ, Dutton JJ (2009) Infiltrative subcutaneous juvenile xanthogranuloma of the eyelid in a neonate. Ophthalmic Plast Reconstr Surg 25(4):330–332
Mocan MC, Bozkurt B, Orhan D, Kuzey G, Irkec M (2008) Juvenile xanthogranuloma of the corneal limbus: report of two cases and review of the literature. Cornea 27(6):739–742
Janssen D, Harms D (2005) Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry. Am J Surg Pathol 29(1):21–28
Dosari SHH, Maktabi A, Alkatan H (2016) Periocular adult-onset Xanthogranuloma (AOX) initially misdiagnosed as Xanthelasma: a Case Report. J Clin Case Stu. https://doi.org/10.16966/2471-4925.117
Alkatan HM, Al-Rajhi AA (2016) Corneal xanthogranuloma in association with multiple endocrine neoplasia 1: A clinicopathologic case report and review of the literature. Saudi J Ophthalmol: Off J Saudi Ophthalmol Soc 30(1):49–52
Sivak-Callcott JA, Rootman J, Rasmussen SL, Nugent RA, White VA, Paridaens D et al (2006) Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol 90(5):602–608
Chalfin S, Lloyd WC (1998) Juvenile xanthogranuloma of the eyelid in an adult. Arch Ophthalmol 116(11):1546–1547
Carstensen H, Ornvold K (1993) Langerhans-cell histiocytosis (histiocytosis X) in children. Ugeskr Laeger 155(23):1779–1783
Rastogi V, Sharma R, Misra SR, Yadav L, Sharma V (2014) Emperipolesis—a review. J Clin Diagn Res 8(12):ZM01–ZM02. https://doi.org/10.7860/JCDR/2014/10361.5299
Goto H, Takahira M, Azumi A (2015) Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol 59(1):1–7
Acknowledgements
This work was supported by the College of Medicine Research Center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia. The authors would also like to thank King Saud University Medical City for the laboratories, materials, manpower, and infrastructure used in support of this work. The authors would like to thank Ms. Priscilla W. Gikandi (MPH), Research Unit, Department of Ophthalmology, College of Medicine, King Saud University for her extensive help with the data management and analysis.
Funding
This work did not receive funding from any of the institutions or funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
All authors have read and approved the manuscript. TAA: Literature review, data collection, and preparation of the first draft of the manuscript. AMYM: Histopathologic review. HMK: Provided histopathology figures and critically revised the manuscript for submission as a corresponding author.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest or financial disclosures in relation to this work.
Ethical approval
This study was conducted in accordance with the ethical standards of the Human Ethics Committee at KKESH and expedited approval as a retrospective study from the HEC/IRB of the Research Department in accordance with the Helsinki Declaration. The study did not include any animal research or trial of medications.
Consent for publication
Written informed consent was obtained from all patients, including permission for anonymous use of data for the purpose of publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Alkatan, H.M., Alzahem, T.A. & Maktabi, A.M.Y. Ophthalmic histiocytic lesions: a baseline demographic and clinicopathological study of 28 cases from two eye centers. Int Ophthalmol 42, 1221–1232 (2022). https://doi.org/10.1007/s10792-021-02108-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-021-02108-1